相关实验视频

Updated: Jun 11, 2025

Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction

Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction

Published on: July 7, 2023

针对GPRC5D的DNA疫苗与PD-1阻断协同,用于治疗多发性骨髓瘤

Praveen Neeli¹, Perry Ayn Mayson A Maza², Dafei Chai²

¹Department of Medicine, Baylor College of Medicine, Houston, TX, 77030, USA. neelipraveen@gmail.com.

|October 1, 2024

概括

这项研究表明,针对GPRC5D的DNA疫苗可以预防和治疗多发性骨髓瘤 (MM). 将GPRC5D疫苗与PD-1封锁结合起来,有效地抑制了小鼠中已建立的MM瘤.

科学领域:

免疫学免疫学免疫学
在瘤学瘤学.
分子生物学分子生物学

背景情况:

多发性骨髓瘤 (MM) 是一种致命的血液性癌症,治疗选择有限.
G蛋白结合受体类C组5成员D (GPRC5D) 在MM血细胞中表达高,使其成为有前途的免疫治疗点.

研究的目的:

调查编码GPRC5D的DNA疫苗的疗效,单独或与PD-1阻断结合,用于预防和治疗多发性骨髓瘤.
用小鼠模型评估预防和治疗潜力.

主要方法:

使用了多发性骨髓瘤的5TGM1小鼠模型.
使用编码小鼠和人类GPRC5D的DNA疫苗.
结合GPRC5D DNA疫苗接种与PD-1阻断疗法.
评估了瘤生长抑制和免疫反应,包括T细胞和抗体诱导.

主要成果:

单独使用GPRC5DDNA疫苗可以预防小鼠骨髓瘤的生长.
已确定的MM瘤需要用GPRC5D疫苗和PD-1阻塞进行组合治疗以抑制.
在小鼠模型中,DNA疫苗接种诱导了GPRC5D特异性T细胞和抗体.
编码人类GPRC5D的纳米塑体载体显示出类似的瘤抑制功效.

结论:

针对GPRC5D的DNA疫苗显示出预防和治疗多发性骨髓瘤的潜力.
结合治疗与PD-1阻断增强了针对已确定的MM的治疗疗效.
GPRC5D DNA 疫苗代表了MM免疫疗法开发的多功能平台.

更多相关视频

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Published on: May 2, 2025

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

相关概念视频

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...